ICON Plc ICLR
NASDAQ · United States · Commercial Services
$169.99-0.36 (-0.21%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Marram Investment Management’s second-quarter 2026 investor letter reports a +2.7% portfolio return (net of fees), resulting in a year-to-date return of +3.2%. A copy of the letter can be downloaded here. Cumulatively, since inception, the firm has achieved a +632.4% return and a +13.7% annualized return, net of fees. Positive contributions came from MLP Energy […]
DUBLIN, August 20, 2026--ICON releases 2025 ICON Cares Report, highlighting progress in patient impact, innovation and sustainability
DUBLIN, August 06, 2026--ICON Announces Pricing of USD 2.15 Billion Notes
ICON and Anthropic announced a multi year collaboration to integrate AI across the clinical trial lifecycle. The partnership is expected to touch areas such as protocol design, site selection, predictive analytics and ecosystem integration. The move aligns with ICON's broader digital and AI plans within the life sciences sector. ICON, traded as NasdaqGS:ICLR, is moving ahead with this collaboration while its share price stands at $156.85. The stock has seen declines of 13.0% over the past...
Greenskeeper Asset Management, an independent firm that specializes in disciplined value investing, recently released its Q2 2026 scorecard. A copy is available to download here. After a slow start to the year, the Fund gained 10.9% in the quarter, lifting its year-to-date return to 1.9%. The rebound came as markets showed signs of rotating away from momentum […]
DUBLIN, August 04, 2026--ICON Announces Private Offering of Notes
DUBLIN, July 31, 2026--ICON Announces Results of Annual General Meeting
Icon PLC (ICLR) reports robust $3.7 billion in gross business wins and a 1.51x book-to-bill ratio, but faces headwinds from elevated pass-through activity impacting gross margins.
DUBLIN, July 29, 2026--ICON Reports Second Quarter 2026 Results
Harris Oakmark recently released its second-quarter 2026 investor letter for the “Oakmark U.S. Concentrated Strategy”. A copy of the letter can be downloaded here. The strategy returned 9.21% (net) in the second quarter, lagging the Russell 1000 Value Index’s 13.87%. U.S. equities finished higher during the quarter, with nine of eleven GICS sectors posting gains, led […]
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.